PILOT STUDY ON MITOCHONDRIAL DNA COPY NUMBER VARIATIONS IN VIETNAMESE BREAST CANCER PATIENTS

Hoàng Tuyết Minh Nguyễn, Quốc Đạt Ngô, Văn Thắng Nguyễn, Quốc Thắng Phạm, Anh Tú Thái, Minh Tâm Phạm, Văn Hùng Phạm, Thị Minh Nhã Đào, Thị Lệ Hương Nguyễn

Main Article Content

Abstract

Background: Changes in mitochondrial DNA copy number (mtDNA-CN) in various tumor types have been linked to an increased risk of cancers. However, studies on their association with breast cancer in Vietnamese patients remain to be determined. In this pilot study, we investigated mtDNA-CN variation in paired normal and cancerous breast tissues and compared their differences. Methods: 12 paired tissues from adjacent normal and tumor sites from the same breast cancer patients were utilized for the study. Total genomic DNA was isolated and changes in mtDNA-CN were measured by relative quantification using the SYBR green based quantitative Real- time PCR method. Results: The R2 correlation for each standard curve was ≥0.98. The 12 individuals, averaging 45.83 years old (± 9.73), were identified with early-stage invasive or locally advanced breast cancer, some with no lymph node involvement (N0) and others with (N1). Tumors, classified as grade 2 or higher, with sizes ranging from 3 to 45 mm. Our results revealed a significant reduction in mtDNA-CN in cancerous breast tissues compared with the normal ones (p=0.0226). Conclusions: Overall, our study reports a comparison of mtDNA-CN in paired normal and cancerous breast tissues and suggests that decreased mtDNA content in breast cancer may have diagnostic value for the disease

Article Details

References

1. Sedeta ET, Jobre B, Avezbakiyev B. Breast cancer: Global patterns of incidence, mortality, and trends. JCO. 2023 Jun 1;41(16_suppl): 10528–10528.
2. Verschoor ML, Ungard R, Harbottle A, Jakupciak JP, Parr RL, Singh G. Mitochondria and Cancer: Past, Present, and Future. BioMed Research International. 2013;2013:1–10.
3. Hsu CC, Tseng LM, Lee HC. Role of mitochondrial dysfunction in cancer progression. Exp Biol Med (Maywood). 2016 Jun;241(12): 1281–95.
4. Bai RK, Chang J, Yeh KT, Lou MA, Lu JF, Tan DJ, et al. Mitochondrial DNA Content Varies with Pathological Characteristics of Breast Cancer. Journal of Oncology. 2011;2011:1–10.
5. Osellame LD, Blacker TS, Duchen MR. Cellular and molecular mechanisms of mitochondrial function. Best Practice & Research Clinical Endocrinology & Metabolism. 2012 Dec; 26(6):711–23.
6. Abd Radzak SM, Mohd Khair SZ, Ahmad F, Patar A, Idris Z, Mohamed Yusoff A. Insights regarding mitochondrial DNA copy number alterations in human cancer (Review). Int J Mol Med. 2022 Jun 16;50(2):104.
7. Xia P, An HX, Dang CX, Radpour R, Kohler C, Fokas E, et al. Decreased mitochondrial DNA content in blood samples of patients with stage I breast cancer. BMC Cancer. 2009 Dec;9(1):454.
8. Cui H, Huang P, Wang Z, Zhang Y, Zhang Z, Xu W, et al. Association of decreased mitochondrial DNA content with the progression of colorectal cancer. BMC Cancer. 2013 Dec; 13(1):110.